At the current share price, the 800,000,000 newly authorized shares would have a street value in excess of $25 million. It is possible that some of the new shares might be used for the "pilots," but if the beverage company is AB, i.e. Inbev out of Europe, the appeal of some TAUG shares may or may not be that intriguing. Also there could be constraints on a public entity, such as the City of Cincinnati, holding penny stocks. TAUG might be able to negotiate share deals with sub-contractors to remove the "end-user" company/municipality from the financing loop. In any case it is a question for which there is no immediate answer. IMO...with $25 million in hand a new source of decent revenue and cash flows would be a major target! With so many current non-revenue generating projects and/or businesses in place, which require continuing capital support, significantly improved free cash flows would help to minimize shareholder dilution that would be the product of using stock to finance general company operations. Assuming the Doc Green's deal is finalized (no reason to think it won't be), this represents some amount of revenue, but the real need is free cash flows! Who knows how much? Also, TAUG has already indicated it is looking to finance expansion in the cannabis/hemp industry. Basically, with the of breadth of TAUG's projects, significant new sources of revenue would help underwrite the multiple development activities! TAUG has done a reasonable job of cleaning up its balance sheet by addressing the debt, but it appears some of the credit burden will ultimately migrate to the shareholders, i.e. dilution. JMHO!
